Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of$ 0.44. This compares to loss of $1.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.27%. A quarter ago, it was expected that this company would post a loss of$ 0.43 per share when it actually produced a loss of $0.28, delivering a surprise of 34.88%.Over the last four quarters, the company has ...